Willingness to participate in a lung cancer screening program: Patients’ attitudes towards United States Preventive Services Taskforce (USPSTF) recommendations

Published:December 20, 2021DOI:
      Like many other cancers, the prognosis of lung cancer largely depends on the stage of cancer at the time of diagnosis and early detection could significantly improve cancer-related morbidity and mortality. Since the early 2000s, it has been shown that low-dose computed tomography (LDCT) screening could be valuable in early detection of lung cancer [
      • Team NLSTR.
      Reduced lung-cancer mortality with low-dose computed tomographic screening.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to European Journal of Internal Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Team NLSTR.
        Reduced lung-cancer mortality with low-dose computed tomographic screening.
        N. Engl. J. Med. 2011; 365: 395-409
        • Force USPST.
        Screening for lung cancer: US preventive services task force recommendation statement.
        JAMA. 2021; 325 ([Internet]Mar 9Available from:): 962-970
        • Silvestri G.A.
        • Nietert P.J.
        • Zoller J.
        • Carter C.
        • Bradford D.
        Attitudes towards screening for lung cancer among smokers and their non-smoking counterparts.
        Thorax. 2007; 62: 126-130
        • Tammemagi C.M.
        • Pinsky P.F.
        • Caporaso N.E.
        • Kvale P.A.
        • Hocking W.G.
        • Church T.R.
        • et al.
        Lung cancer risk prediction: prostate, lung, colorectal and ovarian cancer screening trial models and validation.
        J. Natl. Cancer Inst. 2011; 103: 1058-1068
        • Delmerico J.
        • Hyland A.
        • Celestino P.
        • Reid M.
        • Cummings K.M
        Patient willingness and barriers to receiving a CT scan for lung cancer screening.
        Lung Cancer. 2014; 84: 307-309
        • Garrett B.E.
        • Dube S.R.
        • Winder C.
        • Caraballo R.S.
        Prevention C for DC and. cigarette smoking—United States, 2006–2008 and 2009–2010.
        MMWR Surveill Summ. 2013; 62 (Suppl): 81-84
        • Gressard L.
        • DeGroff A.S.
        • Richards T.B.
        • Melillo S.
        • Kish-Doto J.
        • Heminger C.L.
        • et al.
        A qualitative analysis of smokers’ perceptions about lung cancer screening.
        BMC Public Health. 2017; 17: 1-8
        • Mahadevia P.J.
        • Fleisher L.A.
        • Frick K.D.
        • Eng J.
        • Goodman S.N.
        • Powe N.R.
        Lung cancer screening with helical computed tomography in older adult smokers: a decision and cost-effectiveness analysis.
        JAMA. 2003; 289: 313-322
      1. Jonas D.E., Reuland D.S., Reddy S.M., Nagle M., Clark S.D., Weber R.P., et al. Screening for lung cancer with low-dose computed tomography: an evidence review for the US preventive services task force. 2021.

        • Brenner D.J.
        Radiation risks potentially associated with low-dose CT screening of adult smokers for lung cancer.
        Radiology. 2004; 231: 440-445